FDA.reportPublic FDA data

benzgalantamine 5 MG Delayed Release Oral Tablet

RxCUI
2690632
RxNorm name
benzgalantamine 5 MG Delayed Release Oral Tablet
Display name
benzgalantamine 5 MG Delayed Release Oral Tablet
Full name
benzgalantamine 5 MG Delayed Release Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZUNVEYLBENZGALANTAMINEAlpha Cognition, Inc.af47bf67-1f07-4650-8064-24c38afc46562026-03-17Warnings, Adverse reactionsExact identifier
rxcui: 2690632

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
af47bf67-1f07-4650-8064-24c38afc4656benzgalantamine 5 MG Delayed Release Oral Tablet [PSN] · benzgalantamine 5 MG Delayed Release Oral Tablet [SCD] · benzgalantamine 5 MG (equivalent to benzgalantamine gluconate 7.49 MG) Delayed Release Oral Tablet [SY]35These highlights do not include all the information needed to use ZUNVEYL safely and effectively. See full prescribing information for ZUNVEYL. ZUNVEYL (benzgalantamine) delayed-release tablets, for oral use Initial U.S. Approval: 200120260317